February 28, 2023

Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. September 14, 2023

    Fed. Circ. Won't Touch Hypertension Drug Producer's Loss

    The Federal Circuit declined Thursday to second-guess a patent ruling out of Delaware federal court that ended a drugmaker's control over the market for liquid versions of its hypertension drug Epaned and allowed an Indian drugmaker to start selling a generic version of the medication.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login